PharmaRoth Labs Inc (ROTH)

[old biohf guy]

Several comments here:

Can you explain the missing sentence from your previous post as pointed out by sweetlou?

The FDA denied marketing as a herbal over the counter supplement, but this is not a total denial of th product.

As for re-applying as a drug, this was adressed a while back. The answer is FDA approval requires lot of money which Roth does not have, so Roth decided to market in countries like Canada and Mexico where there is already approval. India should also be approved before the end of this years if all goes well as expected.

IR never said they were not interested in the US market. The US market is for the future.

The $15k for the promotion is mere pocket change compared to the millions it would cost for FDA approval.

As for misleading press releases, can you be specific and tell everyone exactly what was misleading?